Evidence-Based Medicine Guidelines
Levomepromazine for schizophrenia
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Levomepromazine for Schizophrenia." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/457177/all/Levomepromazine_for_schizophrenia.
Levomepromazine for schizophrenia. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/457177/all/Levomepromazine_for_schizophrenia. Accessed June 2, 2023.
Levomepromazine for schizophrenia. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/457177/all/Levomepromazine_for_schizophrenia
Levomepromazine for Schizophrenia [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 June 02]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/457177/all/Levomepromazine_for_schizophrenia.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Levomepromazine for schizophrenia
ID - 457177
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/457177/all/Levomepromazine_for_schizophrenia
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
